JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 33 No. 4 471-477
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merlet, P.
Right arrow Articles by Syrota, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merlet, P.
Right arrow Articles by Syrota, A.

Prognostic Value of Cardiac Metaiodobenzylguanidine Imaging in Patients with Heart Failure

Pascal Merlet, Héric Valette, Jean-Luc Dubois-Randé, Dominique Moyse, Denis Duboc, Patrick Dove, Michel Henri Bourguignon, Christophe Benvenuti, Anne Marie Duval, Denis Agostini, Daniel Loisance, Alain Castaigne and André Syrota

Service de Cardiologie et de Chirurgie Cardio-vasculaire, Centre Hospitalo-Universitaire Henri Mondor, Créteil
Service de Cardiologie, Centre Hospitalo-Universitaire de Cochin, Paris
Centre Médico-Chirurgical de Bligny, Bligny
Service Hospitalier Frédéric Joliot, Commissariat à l'Energie Atomique, Orsay, France

Correspondence: For reprints contact: Pascal Merlet, MD, Service Hospitalier Frédéric Joliot, Commissariat à I'Energie Atomique, 4 place du Général Leclerc, 91401 Orsay, France.

ABSTRACT

The prognostic value of 123I-metaiodobenzylguanidine (MIBG) imaging was compared with that of other noninvasive cardiac imaging indices in ninety patients (mean age = 52 ± 7 yr) suffering from either ischemic (n = 24) or idiopathic (n = 66) cardiomyopathy. Patients had different measurements taken: cardiac MIBG uptake, radionuclide left ventricular ejection fraction, x-ray cardiothoracic ratio and echographic M-Mode data. Cardiac MIBG uptake was assessed as the heart-to-mediastinum activity ratio measured on the chest anterior view image obtained 4 hr after intravenous injection. The patients then had follow-up for 1–27 mo, at which time 10 patients had transplants, 22 had died and 58 were still alive. Data from patients with transplants were not used in the analysis, in which multivariate stepwise regression discriminant analysis showed that cardiac MIBG uptake was more potent to predict survival than other indices: H/M (p < 0.0001), x-ray cardiothoracic ratio (p = 0.0017), echographic end-diastolic diameter (p = 0.0264) and radionuclide left ventricular ejection fraction (p = 0.0301). Moreover, multivariate life table analysis showed that cardiac MIBG uptake was also the best predictor for life duration: H/M (p = 0.0001), radionuclide left ventricular ejection fraction (p = 0.0098) and x-ray cardiothoracic ratio (p = 0.0139); echographic data were not useful. Thus, cardiac MIBG imaging may be helpful for heart transplantation decision making in patients with heart failure.




This article has been cited by other articles:


Home page
 EuropaceHome page
H. Ukkonen, J. Sundell, and J. Knuuti
Effects of CRT on myocardial innervation, perfusion and metabolism
Europace, November 1, 2008; 10(suppl_3): iii114 - iii117.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc ImagingHome page
J. J. Bax, O. Kraft, A. E. Buxton, J. G. Fjeld, P. Parizek, D. Agostini, J. Knuuti, A. Flotats, J. Arrighi, A. Muxi, et al.
123I-mIBG Scintigraphy to Predict Inducibility of Ventricular Arrhythmias on Cardiac Electrophysiology Testing: A Prospective Multicenter Pilot Study
Circ Cardiovasc Imaging, September 1, 2008; 1(2): 131 - 140.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Kasama, T. Toyama, H. Sumino, M. Nakazawa, N. Matsumoto, Y. Sato, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, et al.
Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
J. Nucl. Med., June 1, 2008; 49(6): 907 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
H. J. Verberne, L. M. Brewster, G. A. Somsen, and B. L.F. van Eck-Smit
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review
Eur. Heart J., May 1, 2008; 29(9): 1147 - 1159.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. R. Vesely and V. Dilsizian
Nuclear Cardiac Stress Testing in the Era of Molecular Medicine
J. Nucl. Med., March 1, 2008; 49(3): 399 - 413.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. I. Travin
A Potential Key Role for Radionuclide Imaging in the Prediction and Prevention of Sudden Arrhythmic Cardiac Death
J. Nucl. Med., February 1, 2008; 49(2): 173 - 175.
[Full Text] [PDF]

Home page
 JNMHome page
D. Nagahara, T. Nakata, A. Hashimoto, T. Wakabayashi, M. Kyuma, R. Noda, S. Shimoshige, K. Uno, K. Tsuchihashi, and K. Shimamoto
Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function
J. Nucl. Med., February 1, 2008; 49(2): 225 - 233.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
J. H. Caldwell, J. M. Link, W. C. Levy, J. E. Poole, and J. R. Stratton
Evidence for Pre- to Postsynaptic Mismatch of the Cardiac Sympathetic Nervous System in Ischemic Congestive Heart Failure
J. Nucl. Med., February 1, 2008; 49(2): 234 - 241.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Kasama, T. Toyama, H. Sumino, N. Matsumoto, Y. Sato, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Additive Effects of Spironolactone and Candesartan on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients with Congestive Heart Failure
J. Nucl. Med., December 1, 2007; 48(12): 1993 - 2000.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Tsukamoto, K. Morita, M. Naya, M. Inubushi, C. Katoh, K. Nishijima, Y. Kuge, H. Okamoto, H. Tsutsui, and N. Tamaki
Decreased Myocardial {beta}-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy
J. Nucl. Med., November 1, 2007; 48(11): 1777 - 1782.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
Y. Inui, H. Toyama, Y. Manabe, T. Sato, M. Sarai, K. Kosaka, N. Iwata, and K. Katada
Evaluation of Probable or Possible Dementia with Lewy Bodies Using 123I-IMP Brain Perfusion SPECT, 123I-MIBG, and 99mTc-MIBI Myocardial SPECT
J. Nucl. Med., October 1, 2007; 48(10): 1641 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
H. Kioka, T. Yamada, T. Mine, T. Morita, Y. Tsukamoto, S. Tamaki, M. Masuda, K. Okuda, M. Hori, and M. Fukunami
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging
Heart, October 1, 2007; 93(10): 1213 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Kasama, T. Toyama, T. Hatori, H. Sumino, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol
Eur. Heart J., April 4, 2007; (2007) ehm048v1.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S Kasama, T Toyama, T Hatori, H Sumino, H Kumakura, Y Takayama, S Ichikawa, T Suzuki, and M Kurabayashi
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure
Heart, October 1, 2006; 92(10): 1434 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. J. Buss, J. Backs, M. M. Kreusser, S. E. Hardt, C. Maser-Gluth, H. A. Katus, and M. Haass
Spironolactone Preserves Cardiac Norepinephrine Reuptake in Salt-Sensitive Dahl Rats
Endocrinology, May 1, 2006; 147(5): 2526 - 2534.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S Kasama, T Toyama, T Hatori, H Sumino, H Kumakura, Y Takayama, S Ichikawa, T Suzuki, and M Kurabayashi
Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure
Heart, May 1, 2006; 92(5): 625 - 630.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs
Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts
Hypertension, February 1, 2006; 47(2): 209 - 215.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
G. Munch, K. Rosport, A. Bultmann, C. Baumgartner, Z. Li, L. Laacke, and M. Ungerer
Cardiac Overexpression of the Norepinephrine Transporter Uptake-1 Results in Marked Improvement of Heart Failure
Circ. Res., October 28, 2005; 97(9): 928 - 936.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Mabuchi, M. Imamura, N. Kubo, K. Morita, K. Noriyasu, T. Tsukamoto, K. Yasuda, and N. Tamaki
Sympathetic Denervation and Reinnervation After the Maze Procedure
J. Nucl. Med., July 1, 2005; 46(7): 1089 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction
J. Am. Coll. Cardiol., March 1, 2005; 45(5): 661 - 667.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Ohuchi, H. Takasugi, H. Ohashi, O. Yamada, K. Watanabe, T. Yagihara, and S. Echigo
Abnormalities of Neurohormonal and Cardiac Autonomic Nervous Activities Relate Poorly to Functional Status in Fontan Patients
Circulation, October 26, 2004; 110(17): 2601 - 2608.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. Hiasa, M. Hamada, H. Saeki, A. Ogimoto, T. Ohtsuka, Y. Hara, and Y. Shigematsu
Cardiac Sympathetic Nerve Activity Can Detect Congestive Heart Failure Sensitively in Patients With Hypertrophic Cardiomyopathy
Chest, September 1, 2004; 126(3): 679 - 686.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, T. Ishikawa, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity in Patients with Decompensated Congestive Heart Failure
J. Nucl. Med., July 1, 2004; 45(7): 1108 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Kurata, A. Uehara, and A. Ishikawa
Improvement of Cardiac Sympathetic Innervation by Renal Transplantation
J. Nucl. Med., July 1, 2004; 45(7): 1114 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
Y. J. Akashi, K. Nakazawa, M. Sakakibara, F. Miyake, H. Musha, and K. Sasaka
123I-MIBG Myocardial Scintigraphy in Patients with "Takotsubo" Cardiomyopathy
J. Nucl. Med., July 1, 2004; 45(7): 1121 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
B.-i. Kato, T. Nozawa, N. Igarashi, M. Nonomura, N. Fujii, A. Igawa, H. Asanoi, Y. Yamada, M. Inoue, and H. Inoue
Discrepant Recovery Course of Sympathetic Neuronal Function and {beta}-Adrenoceptors in Rat Hearts After Reperfusion Following Transient Ischemia
J. Nucl. Med., June 1, 2004; 45(6): 1074 - 1080.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Kyuma, T. Nakata, A. Hashimoto, K. Nagao, H. Sasao, T. Takahashi, K. Tsuchihashi, and K. Shimamoto
Incremental Prognostic Implications of Brain Natriuretic Peptide, Cardiac Sympathetic Nerve Innervation, and Noncardiac Disorders in Patients with Heart Failure
J. Nucl. Med., February 1, 2004; 45(2): 155 - 163.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Ohuchi, H. Takasugi, H. Ohashi, Y. Okada, O. Yamada, Y. Ono, T. Yagihara, and S. Echigo
Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients With Congenital Heart Disease
Circulation, November 11, 2003; 108(19): 2368 - 2376.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Toyama, H. Hoshizaki, R. Seki, N. Isobe, H. Adachi, S. Naito, S. Oshima, and K. Taniguchi
Efficacy of Carvedilol Treatment on Cardiac Function and Cardiac Sympathetic Nerve Activity in Patients with Dilated Cardiomyopathy: Comparison with Metoprolol Therapy
J. Nucl. Med., October 1, 2003; 44(10): 1604 - 1611.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Sato, K. Maehara, H. Yaoita, H. Otani, A. Hirosaka, T. Saito, N. Onuki, N. Komatsu, T. Ishihata, and Y. Maruyama
Correlation Between Cardiac Norepinephrine Overflow During Exercise and Cardiac 123I-MIBG Uptake in Patients with Chronic Heart Failure
J. Nucl. Med., October 1, 2003; 44(10): 1618 - 1624.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Addition of Valsartan to an Angiotensin-Converting Enzyme Inhibitor Improves Cardiac Sympathetic Nerve Activity and Left Ventricular Function in Patients with Congestive Heart Failure
J. Nucl. Med., June 1, 2003; 44(6): 884 - 890.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
P. Sipola, E. Vanninen, H. J. Aronen, K. Lauerma, S. Simula, P. Jaaskelainen, M. Laakso, K. Peuhkurinen, J. Kuusisto, and J. T. Kuikka
Cardiac Adrenergic Activity Is Associated with Left Ventricular Hypertrophy in Genetically Homogeneous Subjects with Hypertrophic Cardiomyopathy
J. Nucl. Med., April 1, 2003; 44(4): 487 - 493.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy
J. Am. Coll. Cardiol., February 19, 2003; 41(4): 574 - 581.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. Yamada, T. Shimonagata, M. Fukunami, K. Kumagai, H. Ogita, A. Hirata, M. Asai, N. Makino, H. Kioka, H. Kusuoka, et al.
Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 231 - 238.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Kasama, T. Toyama, H. Kumakura, Y. Takayama, S. Ichikawa, T. Suzuki, and M. Kurabayashi
Spironolactone Improves Cardiac Sympathetic Nerve Activity and Symptoms in Patients with Congestive Heart Failure
J. Nucl. Med., October 1, 2002; 43(10): 1279 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Okuyama, N. Sakane, T. Yoshida, K. Shima, H. Kurosawa, K. Kumamoto, Y. Ushijima, and T. Nishimura
123I- or 125I-Metaiodobenzylguanidine Visualization of Brown Adipose Tissue
J. Nucl. Med., September 1, 2002; 43(9): 1234 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
M E Marketou, E N Simantirakis, V K Prassopoulos, S I Chrysostomakis, A A Velidaki, N S Karkavitsas, and P E Vardas
Assessment of myocardial adrenergic innervation in patients with sick sinus syndrome: effect of asynchronous ventricular activation from ventricular apical stimulation
Heart, September 1, 2002; 88(3): 255 - 259.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. Kasama, T. Toyama, H. Hoshizaki, S. Oshima, K. Taniguchi, T. Suzuki, and M. Kurabayashi
Dobutamine Gated Blood Pool Scintigraphy Predicts the Improvement of Cardiac Sympathetic Nerve Activity, Cardiac Function, and Symptoms After Treatment in Patients With Dilated Cardiomyopathy*
Chest, August 1, 2002; 122(2): 542 - 548.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Pietila, K. Malminiemi, R. Vesalainen, T. Jartti, M. Teras, K. Nagren, P. Lehikoinen, and L.-M. Voipio-Pulkki
Exercise Training in Chronic Heart Failure: Beneficial Effects on Cardiac 11C-Hydroxyephedrine PET, Autonomic Nervous Control, and Ventricular Repolarization
J. Nucl. Med., June 1, 2002; 43(6): 773 - 779.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. Watanabe, T. Takahashi, M. Nakazawa, M. I. I. Wahed, K. Fuse, N. Tanabe, M. Kodama, Y. Aizawa, H. Ashino, and S. Tazawa
Effects of Carvedilol on Cardiac Function and Cardiac Adrenergic Neuronal Damage in Rats with Dilated Cardiomyopathy
J. Nucl. Med., April 1, 2002; 43(4): 531 - 535.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
P. Merlet, L. Hittinger, J. L. Dubois-Rande, and A. Castaigne
Myocardial Adrenergic Dysinnervation in Dilated Cardiomyopathy: Cornerstone or Epiphenomenon?
J. Nucl. Med., April 1, 2002; 43(4): 536 - 539.
[Full Text] [PDF]

Home page
 JNMHome page
M. Shimizu, H. Ino, M. Yamaguchi, H. Terai, K. Hayashi, K. Nakajima, J. Taki, and H. Mabuchi
Heterogeneity of Cardiac Sympathetic Nerve Activity and Systolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
J. Nucl. Med., January 1, 2002; 43(1): 15 - 20.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
H Ogita, T Shimonagata, M Fukunami, K Kumagai, T Yamada, Y Asano, A Hirata, M Asai, H Kusuoka, M Hori, et al.
Prognostic significance of cardiac 123I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study
Heart, December 1, 2001; 86(6): 656 - 660.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Wakabayashi, T. Nakata, A. Hashimoto, S. Yuda, K. Tsuchihashi, M. I. Travin, and K. Shimamoto
Assessment of Underlying Etiology and Cardiac Sympathetic Innervation to Identify Patients at High Risk of Cardiac Death
J. Nucl. Med., December 1, 2001; 42(12): 1757 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Yoshita, J Taki, and M Yamada
A clinical role for [123I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies
J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 583 - 588.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Ohuchi, S. Hasegawa, K. Yasuda, O. Yamada, Y. Ono, and S. Echigo
Severely Impaired Cardiac Autonomic Nervous Activity After the Fontan Operation
Circulation, September 25, 2001; 104(13): 1513 - 1518.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
F.M. Bengel, B. Permanetter, M. Ungerer, S.G. Nekolla, and M. Schwaiger
Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography
Eur. Heart J., September 1, 2001; 22(17): 1594 - 1600.
[Abstract] [PDF]

Home page
 JNMHome page
M. Momose, H. Kobayashi, H. Ikegami, H. Nagamatsu, Y. Sakomura, S. Aomi, H. Kasanuki, and K. Kusakabe
Total and Partial Cardiac Sympathetic Denervation After Surgical Repair of Ascending Aortic Aneurysm
J. Nucl. Med., September 1, 2001; 42(9): 1346 - 1350.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Sato, I. Horigome, S. Chiba, T. Furuta, M. Miyazaki, O. Hotta, K. Suzuki, H. Noshiro, and Y. Taguma
Autonomic insufficiency as a factor contributing to dialysis-induced hypotension
Nephrol. Dial. Transplant., August 1, 2001; 16(8): 1657 - 1662.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Zhao, N. Shuke, W. Yamamoto, A. Okizaki, J. Sato, Y. Ishikawa, T. Ohta, N. Hasebe, K. Kikuchi, and T. Aburano
Comparison of Cardiac Sympathetic Nervous Function with Left Ventricular Function and Perfusion in Cardiomyopathies by 123I-MIBG SPECT and 99mTc-Tetrofosmin Electrocardiographically Gated SPECT
J. Nucl. Med., July 1, 2001; 42(7): 1017 - 1024.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
I. Carrio
Cardiac Neurotransmission Imaging
J. Nucl. Med., July 1, 2001; 42(7): 1062 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
P Acar, P Merlet, L Iserin, D Bonnet, D Sidi, A Syrota, and J Kachaner
Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy
Heart, June 1, 2001; 85(6): 692 - 696.
[Abstract] [Full Text]

Home page
 Eur Heart JHome page
E.N Simantirakis, V.K Prassopoulos, S.I Chrysostomakis, G.E Kochiadakis, S.I Koukouraki, J.P Lekakis, N.S Karkavitsas, and P.E Vardas
Effects of asynchronous ventricular activation on myocardial adrenergic innervation in patients with permanent dual-chamber pacemakers. An I123-metaiodobenzylguanidine cardiac scintigraphic study
Eur. Heart J., February 2, 2001; 22(4): 323 - 332.
[Abstract] [PDF]

Home page
 CirculationHome page
H. Ohuchi, H. Suzuki, K. Toyohara, K. Tatsumi, Y. Ono, Y. Arakaki, and S. Echigo
Abnormal Cardiac Autonomic Nervous Activity After Right Ventricular Outflow Tract Reconstruction
Circulation, November 28, 2000; 102(22): 2732 - 2738.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. A. Beller and B. L. Zaret
Contributions of Nuclear Cardiology to Diagnosis and Prognosis of Patients With Coronary Artery Disease
Circulation, March 28, 2000; 101(12): 1465 - 1478.
[Full Text] [PDF]

Home page
 ChestHome page
F. Sakamaki, T. Satoh, N. Nagaya, S. Kyotani, N. Nakanishi, and Y. Ishida
Abnormality of Left Ventricular Sympathetic Nervous Function Assessed by 123I-Metaiodobenzylguanidine Imaging in Patients With COPD*
Chest, December 1, 1999; 116(6): 1575 - 1581.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
S Orimo, E Ozawa, S Nakade, T Sugimoto, and H Mizusawa
123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 189 - 194.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. Sakata, M. Shirotani, H. Yoshida, R. Nawada, K. Obayashi, K. Togi, and N. Miho
Effects of Amlodipine and Cilnidipine on Cardiac Sympathetic Nervous System and Neurohormonal Status in Essential Hypertension
Hypertension, June 1, 1999; 33(6): 1447 - 1452.